Change management is constant in most biomanufacturing organizations and is often avoided due to perceived complexity. While changes are necessary, they can also offer the opportunity to improve process control, efficiency, or costs. In this webinar, we describe a scientific, risk-based approach to change management and a roadmap for biomanufacturers to expedite changes in their post-approval processes.
Suppliers have extensive product testing information and experience with implementing both process and product changes. By partnering with a collaborative supplier, you can leverage their support to streamline risk assessments and the change management process aligned with ICH Q12 guidance.
In this webinar, you will learn:
- Some process changes don’t need approval!
- Understanding your change — how classification impacts reporting
- How customers can benefit from their supplier’s experience and data packages
- How a ‘change mindset’ supports confident decision making
Speakers
Janmeet Anant, Ph.D.
MilliporeSigma
Senior Regulatory Consultant
Janmeet Anant has been providing regulatory consulting for biopharmaceutical manufacturers for more than 10 years. Janmeet has a global Regulatory Affairs Certification (RAC), a B.S. in Chemistry, and a Ph.D. in Pharmacology.
Pascale Richert
MilliporeSigma
Validation Services Consultant
Pascale Richert provides regulatory and validation expertise to biopharma customers with a focus on sterilizing filtration systems validation. For more than 25 years, she has helped drug manufacturers demonstrate that their filtration systems contribute to safe drug manufacturing. She is a member of PDA and holds a master’s degree in biochemistry and microbiology.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
Duration:1h
Language:English
Session 1:presented December 14, 2023
To continue reading please sign in or create an account.
Don't Have An Account?